CCL20 is a potential therapeutic target associated with immune infiltration in breast cancer

OBJECTIVES: CCL20 is a chemotactic factor that is involved in immune cell recruitment and cancer progression. However, the role of CCL20 in the prognosis of breast cancer remains unclear. This study analyzed correlations between CCL20 expression and immune infiltration, clinicopathological parameter...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Hongyan, Zhang, Na, Mo, Dan, Qin, Tingting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Pre-Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423453/
https://www.ncbi.nlm.nih.gov/pubmed/37571985
http://dx.doi.org/10.1177/03000605231171762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423453/
https://www.ncbi.nlm.nih.gov/pubmed/37571985
http://dx.doi.org/10.1177/03000605231171762

Ejemplares similares